Use of High-Sensitivity Cardiac Troponin in Patients with Kidney Impairment
Peter J. Gallacher,Eve Miller-Hodges,Anoop S.V. Shah,Atul Anand,Neeraj Dhaun,Nicholas L. Mills,Nicholas L Mills,Fiona E Strachan,Christopher Tuck,Anoop SV Shah,Tariq Farrar,Nynke Halbesma,James Blackmur,Andrew R Chapman,Amy V Ferry,Kuan Ken Lee,Dennis Sandeman,Philip D Adamson,Catherine L Stables,Catalina A Vallejos,Athanasios Tsanas,Lucy Marshall,Stacey D Stewart,Takeshi Fujisawa,Mischa Hautvast, Jean McPherson, Lynn McKinlay,David E Newby,Keith AA Fox,Colin Berry,Simon Walker,Christopher J Weir,Alasdair Gray,Paul O Collinson,Fred S Apple,Alan Reid,Anne Cruikshank,Iain Findlay,David A McAllister,Donogh Maguire,Jack PM Andrews,Alastair Moss,Mohamed S Anwar,John Hung,Jonathan Malo,Colin Fischbacher,Bernard L Croal,Stephen J Leslie,Catriona Keerie,Richard A Parker,Allan Walker,Ronnie Harkess,Tony Wackett, Roma Armstrong,Laura Stirling,Claire MacDonald,Imran Sadat,Frank Finlay,Heather Charles,Pamela Linksted,Stephen Young, Bill Alexander,Chris Duncan JAMA Internal Medicine（2021）
摘要
This randomized clinical trial examines the use of high-sensitivity cardiac troponin testing for patients with kidney impairment.
更多查看译文
关键词
Troponin Assays,Cardiac Imaging
AI 理解论文
溯源树
样例
